In comparative studies, patients on SGLT2 inhibitors had a roughly 25% to 30% lower risk of stones than those on GLP-1s
Semaglutide doesn't shrink your stomach, but it does slow how quickly food leaves it, which creates early fullness
Mechanistic investigations in transgenic and toxininduced models of Alzheimer's and Parkinson's diseases have demonstrated that GLP1R activation attenuates microglial activation, suppresses NFB signalling, and restores mitochondrial biogenesis and ATP production
What to Avoid : Never reuse needles, as this can increase the risk of infection
From myocardial infarction to symptomatic PAD, the clinical evidence is clear: GLP-1 therapy is now a cornerstone of secondary CV prevention
FDA Approval Status: A Key Distinction It is important to understand the official standing of these treatments: Oral Glutathione Tablets are FDA approved for treating serious illnesses like liver diseases and for patients undergoing chemotherapy Intravenous (IV) Glutathione does not have FDA approval for the purpose of skin lightening Furthermore, the specific long-term side effects that may occur from using IV Glutathione for cosmetic purposes are currently unknown Side Effects of Oral Tablets (Lower Risk) Oral Glutathione generally has few side effects
